7 February 2020 - Deborah Wilkes
Archived
Australia's Advisory Committee on Medicines Scheduling (ACMS) has recommended two triptans – sumatriptan and zolmitriptan – should be switched from prescription to non-prescription status for treating migraine.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.